SyBridge Technologies Completes Acquisition of X-Cell Tool and Mold
February 1, 2021
SyBridge Technologies announced that it has completed the acquisition of X-Cell Tool and Mold, Inc. This transaction marks the first acquisition by SyBridge in the medical tooling industry and supplements SyBridge's presence in the mobility end market through its Concours Technologies subsidiary. "New York based private equity firm Crestview Partners established SyBridge Technologies in 2019 and committed $200 million of equity to create a market leader spanning across end markets, geographies and advanced technological capabilities to provide value-added manufacturing solutions to its customers," said a spokesperson.
Located in Fairview, PA, X-Cell is a manufacturer of close-tolerance and multi-cavity plastic injection molds primarily for the medical industry while also serving the consumer goods and electronics industries. "The company was founded in 1996 and utilizes state of the art engineering and manufacturing capabilities to provide precise and effective customer tooling," said the spokesperson.
The acquisition of X-Cell expands SyBridge's tooling capabilities to include highly complex precision tooling solutions necessary for the medical industry. As a part of SyBridge, X-Cell will be able to leverage design, engineering, supply chain and production capabilities to better serve and grow with its customers.
For more information contact:
SyBridge Technologies
20700 Civic Center Dr., Ste. 430
Southfield, MI 48076
www.sybridgetech.com
X-Cell Tool and Mold, Inc.
7701 Klier Drive S
Fairview, PA 16415
814-474-9100
www.xctam.com
Crestview Partners
www.crestview.com
< back